HERO announces board of directors, adds two new members
The Health Enhancement Research Organization (HERO) announced today the appointment of Jack Groppel, Ph.D., and Shelly Wolff, Ph.D., to the HERO board of directors. HERO is a global nonprofit organization dedicated to advancing research and best practices for workplace and community health and well-being. Its members include organizations – such as public and private companies, health plans, colleges and universities, hospitals and health systems, wellness providers, and municipalities – that strive to create environments where people can be well and thrive.
HERO board members volunteer to provide oversight and direction to guide the growth and evolution of HERO and to shape the broader conversation on improving workplace and community health and well-being.
“The HERO board benefits from a diverse collection of informed voices in the health care industry. These individuals are well known for thoughtful leadership and they bring valuable insight to the conversations around well-being,” said Karen Moseley, president, HERO. “Our board members are passionate about health and well-being and committed to the collaborative approach that is at the heart of everything we do at HERO. They provide a depth of knowledge and experience that will benefit the organization as we work to enhance the broader understanding of how to create healthy, thriving workplaces and communities.”
Jack Groppel, Ph.D.: An internationally recognized pioneer in the science of human performance, Groppel is co-founder of the Johnson & Johnson Human Performance Institute; co-chair of HERO’s Workplace Performance Study Committee; and the national spokesperson for the CEO Pledge for Physical Activity of the National Coalition of Promoting Physical Activity. Groppel co-authored the books, “The Corporate Athlete” and “The Corporate Athlete Advantage” and developed a training program around the concept. He has been featured in the New York Times, Fortune, Forbes, Fast Company, and Huffington Post, among other publications.
“Throughout my career, I have coached Olympic gold medalists, military Special Forces, surgeons and Fortune 500 CEOs, all with one thing in common: a need to perform at their best. These experiences have taught me that individual wellbeing and performance cannot be separated. Organizations like HERO and its members play a vital role in ensuring employees have the support and tools they need to perform at their best, both at work and in life. I’m honored to join their board of directors and look forward to working together to advance the field of workplace wellbeing.”
Shelly Wolff, Ph.D.:As health and workforce effectiveness leader for Willis Towers Watson, Wolff is a national and international expert in health and benefits practice and provides strategic consulting services in the physical, emotional, and financial aspects of organizational and personal health. She has expertise in care and condition management, wellness and prevention, health incentive design, onsite health centers, health care delivery innovations, worksite-based support, emotional health, and financial well-being, among other areas. Wolff is a regular contributor to Willis Towers Watson’s published research on global and domestic health and well-being strategies, programs, and impacts. She received a Master’s in Business Administration from the University of St. Thomas in Minneapolis and a Master’s in vocational rehabilitation from the University of Minnesota.
Groppel and Wolff join an existing HERO board that includes:
Seth Serxner, chief health officer and senior vice president, population health, Optum;
Anita Shaughnessy, vice president, benefits manager, Wells Fargo;
Joni Troester, assistant vice president, total rewards, University of Iowa;
Marleece Barber, M.D., chief medical officer, Lockheed Martin;
Ron Goetzel, vice president of consulting and applied research, IBM Watson Health and senior scientist and director of the Institute for Health and Productivity Studies (IHPS) at the Johns Hopkins Bloomberg School of Public Health;
Karen Moseley, president, HERO;
Josh Glynn, global health and performance manager, Google;
Nico Pronk, president, HealthPartners Institute and chief science officer, HealthPartners, Inc.;
Betty-Jo Saenz, senior director, benefits, DHL;
David Schweppe, national vice president, customer analytics and reporting, Kaiser Permanente;
Dexter Shurney, M.D., chief medical officer, Zipongo;
Tamara Simon, managing director and global practice leader, knowledge resource center, Conduent Human Resource Services; and
Laurie Whitsel, director of policy research, American Heart Association.
The new board members replaced outgoing board members Sue Willette, senior vice president, employer healthcare strategy, Consortium Health Plans; and Lilly Wyttenbach, executive director, JPMorgan Chase & Co. All HERO board members serve three-year terms.
For more information:
Barbara Tabor, HERO / (+1 651-450-1342) /[email protected]
About HERO–Based in Waconia, MN, HERO (the Health Enhancement Research Organization) is a not-for-profit, 501(c)3 corporation that was established in 1997. HERO is dedicated to identifying and sharing best practices that improve the health and well-being of employees, their families and communities. To learn more, visit www.hero-health.org.Follow us on Twitter@heroehm or LinkedIn.